Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.22.2
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Accrued liabilities:    
General and administrative $ 1,008 $ 794
Clinical trial related costs 1,153 1,134
Non-clinical research and manufacturing operations 3,653 2,153
Payroll related 3,408 5,388
Other accrued expenses 69 46
Total Accrued liabilities $ 9,291 $ 9,515